November 2024

The Niemann-Pick Foundation donates nearly 105,000 euros to continue with the clinical trial of a drug to stop the disease-related cognitive deterioration

Dr. Gascón thanked the tireless effort of the Niemann-Pick Foundation to
promote research as a tool to improve patients' quality of life.
Efavirenz is an antiretroviral drug used in HIV treatment that improves the
function of an enzyme that regulates cholesterol.

The Niemann-Pick Foundation donates nearly 105,000 euros to continue with the clinical trial of a drug to stop the disease-related cognitive deterioration Read More »

A new study carried out in Bellvitge warns about the bone mass loss after bariatric surgery

A new study by IDIBELL and Bellvitge University Hospital, published in the journal Bone, reveals that some bariatric surgeries can have an impact on bone health, especially in the hip area.

A new study carried out in Bellvitge warns about the bone mass loss after bariatric surgery Read More »

BioCluster, gamification and innovation in health: IDIBELL’s participation in the Smart City Expo World Congress 2024

The Innovation and Health Biocluster presents itself as a key alliance to position L’Hospitalet in research and advanced medicine.

BioCluster, gamification and innovation in health: IDIBELL’s participation in the Smart City Expo World Congress 2024 Read More »

Establishing safe nursing coverage can prevent complications with the peripheral venous catheter, according to two new GRIN-IDIBELL publications

Two recent studies led by the GRIN-IDIBELL Nursing Research Group show the impact of the number of nurses and the complexity of care on complications associated with the peripheral venous catheter of patients treated in hospitalization and emergencies.

Establishing safe nursing coverage can prevent complications with the peripheral venous catheter, according to two new GRIN-IDIBELL publications Read More »

Scroll to Top